Paul is a co-founder of Achieve Clinics and serves as the company’s Chief Financial Officer and Chief Business Officer.

Paul’s professional experience spans more than 15 years across public and private investments, corporate development, and finance. His finance career began as a biotech equity analyst at Goldman Sachs supporting the firm’s coverage of large and small cap biotechnology stocks, followed by a tenure with San Diego-based Boxer Capital/Tavistock Life Sciences where he performed public and private investment diligence and provided strategic oversight for select venture holdings.

Most recently, Paul has been Founder and Managing Partner of Eldred Advisors, an independent advisory practice focused on strategic transactions and corporate development across the life sciences, including projects in CAR/TCR-T, gene editing, nephrology, rare disease, immunology, and infectious disease.

Paul’s other corporate experiences include serving as Director of Strategy and Corporate Development at Kiromic BioPharma, a Houston-based AI-driven CAR-T company, and as a member of the Finance and Strategy group at Amgen. Paul also served on the Board of Directors of Nasdaq-listed Stellar Biotechnologies, Inc. until its acquisition in 2019.